Department of Health and Human Services$1.1M obligationsEnds Dec 18, 2021
Federal contract award
75N91022F00079
BASE PERIOD: SCIENTIFIC SUPPORT SERVICES, COMMUNICATIONS EDITOR SCIENTIFIC 8, 9, 10, FOR THE OFFICE OF THE CLINICAL DIRECTOR, CENTER FOR CANCER RESEARCH, NATIONAL CANCER INSTITUTES
Award details
Obligations, current value and potential value describe different measures; they are never added together.
| Field | Reported value |
|---|---|
| Agency | Department of Health and Human Services |
| Office | NIH NCI |
| NAICS | 541712 |
| PSC | R499 — Other Professional Services |
| Parent award / vehicle | HHSN261201700002B |
| Set-aside | Not reported |
| Pricing type | LABOR HOURS |
| Obligations | $127.7K |
| Current contract value | $127.7K |
| Potential contract value / ceiling | $243.0K |
| Start date | May 9, 2022 |
| Current end date | May 8, 2024 |
| Potential end date | May 8, 2025 |
| Latest award activity | Aug 31, 2026 |
| Source loaded | Sep 26, 2026 |
Funding and modification history
Showing the latest 3 of 3 loaded transactions. Negative values are deobligations.
| Date | Modification | Obligation change | Description |
|---|---|---|---|
| Aug 31, 2026 | P00002 | $-85.4K | FY26 UDO INITIATIVE; BASE PERIOD: SCIENTIFIC SUPPORT SERVICES, COMMUNICATIONS EDITOR SCIENTIFIC 8, 9, 10, FOR THE OFFICE OF THE CLINICAL DIRECTOR, CENTER FOR CANCER RESEARCH, NATIONAL CANCER INSTITUTES |
| May 8, 2023 | P00001 | $109.7K | BASE PERIOD: SCIENTIFIC SUPPORT SERVICES, COMMUNICATIONS EDITOR SCIENTIFIC 8, 9, 10, FOR THE OFFICE OF THE CLINICAL DIRECTOR, CENTER FOR CANCER RESEARCH, NATIONAL CANCER INSTITUTES |
| May 5, 2022 | 0 | $103.4K | BASE PERIOD: SCIENTIFIC SUPPORT SERVICES, COMMUNICATIONS EDITOR SCIENTIFIC 8, 9, 10, FOR THE OFFICE OF THE CLINICAL DIRECTOR, CENTER FOR CANCER RESEARCH, NATIONAL CANCER INSTITUTES |
Research next steps
- Verify whether remaining options may extend performance beyond the current end date.
- Confirm the ordering vehicle and your eligibility or a qualified teaming route.
- Review the award scope and buyer evidence before making a bid/no-bid decision.